Dr. Steven Dubinett, a lung cancer researcher in the UCLA Jonsson Comprehensive Cancer Center, has been honored by the American Lung Association for his work on research and treatment of lung cancer.
Dubinett, was honored at the association’s Lung Force Gala for advancing academic, clinical and community partnerships designed to accelerate scientific discoveries and clinical breakthroughs in order to improve the health of people worldwide.
Dubinett, who is also a professor of medicine, pathology and laboratory medicine, and molecular and medical pharmacology at the David Geffen School of Medicine at UCLA, began his research in lung cancer more than 30 years ago. Starting his research at UCLA in 1988, he focused on determining why people with lung cancer were not responding to immunotherapy. The American Lung Association was the first organization to award him a grant so that he could study the nature of immune suppression in non-small cell lung cancer, the most common type of lung cancer.
His research continues to focus on immunity and inflammation in the development and treatment of lung cancer and is now supported through the Stand Up To Cancer Dream Team, as well as, grants from the National Cancer Institute, Department of Defense and Department of Veteran Affairs.
